MedPath

a multi-center, phaseII, prospective randomized study to investigate optimal duration of prophylactic antimicrobial agent in patients who undergo pancreatico-duodenectomy following preoperative biliary drainage

Not Applicable
Conditions
Patients without a symptom of cholangitis who have a planned pancreaticoduodenectomy following preoperative biliary drainage.
Registration Number
JPRN-UMIN000007277
Lead Sponsor
Department of Surgery, Kansai Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1. a patient with a symptom of cholangitis after preoperative biliary drainage. 2. a patient with anaerobic bacteria detected after preoperative biliary drainage. 3. a patient with resistant bacteria detected after preoperative biliary drainage. 4. a young patient and a patient who has difficulty in self-decision-making 5. a patient who is inappropriate for study entry by a chief doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of surgical site infection
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath